What's happening
This bill repeals a 2022 law requiring New York to determine federal funding eligibility for certain prescription digital therapeutics.
Why it matters
Potentially slows or halts state-level exploration of Medicaid/insurance funding for prescription digital therapeutics. (such as app-based treatments for mental health or substance use), which could affect access for patients who might have benefited from these technologies.
Signals a shift in legislative priorities or skepticism about the value, cost-effectiveness, or readiness of prescription digital therapeutics. in New York’s public health system, possibly reflecting concerns about evidence, regulation, or budget impact.
May delay or complicate future efforts to secure federal matching funds for digital health tools. by removing the requirement to assess and prepare for such funding, potentially putting New York behind other states in digital health innovation.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
End Digital Drug Program
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Substituted by A988
- Ordered to third reading cal.65
- Referred to rules
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Repeal Digital Therapy Coverage
Signed by Governor · Sponsor Linda Rosenthal
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
856
2023-2024 Regular Sessions
IN SENATE
January 6, 2023
Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Rules
AN ACT to repeal section 1 of a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics, as proposed in legislative bills numbers S. 559 and A.
3642, in relation to prescription digital therapeutics
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 1 of a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics, as proposed in legislative bills numbers S. 559 and A. 3642, is REPEALED.
§ 2. This act shall take effect on the same date and in the same manner as a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics, as proposed in legislative bills numbers S. 559 and A. 3642, takes effect.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD04214-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to repeal section 1 of a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeu- tics, as proposed in legislative bills numbers S. 559 and A. 3642, in relation to prescription digital therapeutics
Purpose
This is a chapter amendment that makes changes to provisions of L.2022, c. , relating to determining whether the state can claim federal participation for coverage of and payment for certain prescription digital therapeutics.
Summary of provisions
Changes included in this Chapter strike the statement of legislative intent. The remainder of the underlying legislation is unchanged.
The underlying legislation directs the Department of Health to seek guidance from the Centers for Medicare & Medicaid Services (CMS) on if the state can claim federal financial participation for certain prescription digital therapeutics to treat substance use and opioid use disorders.
Digital therapeutics deliver software-generated therapeutic inter- ventions directly to patients to prevent, manage, or treat a medical disorder or disease and include interventions such as the digital deliv- ery of physical exercises, behavioral therapy, and education for chronic back pain patients, and a personalized digital program to help people prevent the onset of diabetes and other chronic diseases.
Existing law
None
Justification
This legislation is a negotiated change to the underlying Chapter.
Legislative history
Chapter amendment to Chapter of the Laws of 2022. S.559 and A.3642 both passed the Senate and Assembly in.
Fiscal implications
None
Effective date
This act shall take effect on the same date and in the same manner as Chapter of the Laws of 2022, proposed as legislative bill numbers S.559 and, A.3642; immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.